Clinical trial
The Arterial Revascularization Therapies Study Part II.
NCT00235170 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00235170 |
|---|---|
| Title | The Arterial Revascularization Therapies Study Part II. |
| Official title | ARTS II: Arterial Revascularization Therapies Study Part II of the Sirolimus-Eluting Bx VELOCITY™ Balloon Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions. |
| Acronym | ARTS II |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | drug-eluting stent |
| Enrollment | 607 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Apr 1, 2009 |
| First posted | Oct 10, 2005 |
| Last update posted | May 5, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: